Article Figures & Data
Figures
- Figure 1.
Primary End Point Data for RADIANT-3
The P value was obtained from a stratified one-sided log-rank test and the HR was obtained from a stratified unadjusted Cox model.
PFS, progression-free survival.
From Yao JC et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514–523. Copyright © 2011 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
- Figure 2.
Final Overall Survival Analysis by RPSFT
Reproduced with permission from JC Yao, MD.
KM, Kaplan-Meier; RPSFT, rank-preserving structural failure time.
aReconstructed placebo data as if never treated with everolimus.
Tables
Tools
Everolimus Safe and Effective for Advanced pNET: Final Results of RADIANT-3
Permalink:
Table of contents
Cited By...
- No citing articles found.